Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
131,516,365
-
Total 13F shares
-
65,565,499
-
Share change
-
+1,096,378
-
Total reported value
-
$7,859,319,459
-
Put/Call ratio
-
121%
-
Price per share
-
$119.87
-
Number of holders
-
274
-
Value change
-
+$143,389,344
-
Number of buys
-
172
-
Number of sells
-
102
Institutional Holders of ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) as of Q2 2015
As of 30 Jun 2015 ALNYLAM PHARMACEUTICALS, INC. - COMMON STOCK (ALNY) had 274 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,565,499 shares of stock of the company.
Largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, Capital World Investors, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., PRICE T ROWE ASSOCIATES INC /MD/, FIRST TRUST ADVISORS LP, and GILDER GAGNON HOWE & CO LLC.
This table shows 274 institutional shareholders of the security as of 30 Jun 2015.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.